- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04538768
Prevention of Lateral Incisional Hernia After Stomal Closure Using P4HB Retro-muscular Mesh
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Leo Licari, MD
- Phone Number: +39 3401710089
- Email: lele.licari@gmail.com
Study Contact Backup
- Name: Cosimo Callari, MD
- Phone Number: +39 339 4574404
- Email: cosimo.callari@gmail.com
Study Locations
-
-
-
Palermo, Italy, 90100
- Ospedale Buccheri La Ferla Palermo
-
Contact:
- Leo Licari, MD
- Phone Number: +39 3401710089
- Email: lele.licari@gmail.com
-
Contact:
- Cosimo Callari, MD
- Phone Number: +39 3394574404
- Email: cosimo.callari@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients > 18 y.o.
- stomal closure
- elective surgery
Exclusion Criteria:
- patients < 18 y.o.
- emergency surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mesh Augmentated
|
P4HB retromuscular mesh placement for prevention of lateral incisional hernia after stomal closure
|
|
Other: Direct Suture
|
direct fascia suture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of postoperative lateral incisional hernia after P4HB mesh placement vs direct fascia suture.
Time Frame: 1 week to 18 months after surgery
|
the outcome 1 will be assessed through clinical examination during follow up time.
when the suspicion of incisional hernia will be hypothesized the patients will be conducted to perform US of the abdomen and CT scan of the abdomen if strictly required to confirm the suspicion.
|
1 week to 18 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
surgical operation time in P4HB mesh placement group vs direct fascia suture group.
Time Frame: intraoperative
|
outcome 2 will be assessed through the measurement of the length of surgical operation.
The length of the surgical operation will be measured in minutes from the incision of the skin to the suture of the skin.
data will be compared with those of the control arm (direct fascia suture) to understand the feasibility of the technique proposed.
|
intraoperative
|
|
length of hospital stay in P4HB mesh placement group vs direct fascia suture group.
Time Frame: From the starting date of the study until the date of its completion, assessed up to 18 months"
|
outcome 3 will be assessed through the measurement of the length of the hospital stay.
The length of hospital stay will be measured in days from admission to dimission of the patient.
Data will be compared with those of the control arm (direct fascia suture).
|
From the starting date of the study until the date of its completion, assessed up to 18 months"
|
|
rate of surgical site infection in P4HB mesh placement group vs direct fascia suture group.
Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
outcome 4 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complication such as surgical site infection.
|
1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
|
rate of seroma formation in P4HB mesh placement group vs direct fascia suture group.
Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
outcome 5 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as seroma.
|
1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
|
rate of hematoma formation in P4HB mesh placement group vs direct fascia suture group.
Time Frame: 1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
outcome 6 will be assessed through clinical examination during follow up time evaluating the rate of postoperative complications such as hematoma.
|
1 week after surgery; 1 month after surgery; 3 months after surgery; 6 months after surgery; 12 months after surgery; 18 months after surgery
|
|
assessment of quality of life (QoL) through QoL scale in P4HB mesh placement group vs direct fascia suture group.
Time Frame: 18 months after surgery.
|
outcome 7 will be assessed through assessment of the postoperative QoL. The SF-36 questionnaire will be administered post-operatively. The 36-Item Short Form Health Survey questionnaire (SF-36) is a very popular instrument for evaluating Health-Related Quality of Life. The SF-36, as described in the name, is a 36-item patient-reported questionnaire that covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state. |
18 months after surgery.
|
|
cost effectiveness analysis of the P4HB mesh augmentation technique vs direct fascia suture group.
Time Frame: through study completion, an average of 1 year .
|
the outcome 8 will be assessed through the collection of data about the total costs for the surgical operation and the hospitalization considering materials and mesh used.
The analysis will be used to compare the costs of the technique proposed with those of the incisional hernia management in order to conduct a cost effectiveness analysis.
|
through study completion, an average of 1 year .
|
Collaborators and Investigators
Investigators
- Study Director: Leo Licari, MD, Ospedale Buccheri La Ferla Palermo; University of Palermo - Department of Surgical, Oncological and Oral Sciences
- Study Chair: Cosimo Callari, MD, Ospedale Buccheri La Ferla Palermo
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20082020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Incisional LLQ Hernia
-
W.L.Gore & AssociatesActive, not recruitingHernia, Ventral | Hernia Incisional | Hernia Incisional VentralUnited States, United Kingdom, Italy, Spain
-
The Cleveland ClinicJoseph and Florence Mandel Family FoundationRecruitingHernia | Hernia Surgery | Hernia Incisional | Hernia Incisional Ventral | Hernia Abdominal Wall | Hernia Repair With Compartment Syndrome | Botox InjectionUnited States
-
Zagazig UniversityCompletedIncisional Hernia of Midline of Abdomen | Incisional Hernia of Midline of Upper Abdomen | Incisional Hernia of Midline of Lower AbdomenEgypt
-
Mansoura UniversityUnknownHernia, Abdominal | Hernia, Ventral | Hernia IncisionalEgypt
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAssessment of Intra-abdominal Pressure During the Perioperative Period of Hernia Repair (PRESSEVENT)Hernia IncisionalFrance
-
Medtronic - MITGCompletedVentral Incisional HerniaFrance
-
Hospital Regional de Alta Especialidad del BajioCompleted
-
Hospital Central "Dr. Ignacio Morones Prieto"UnknownHernia, Ventral | Ventral Incisional Hernia
-
The Cleveland ClinicAbdominal Core Health Quality CollaborativeCompletedHernia, Ventral | Hernia IncisionalUnited States
-
C. R. BardCompletedHernia | Hernia, Abdominal | Hernia, IncisionalBelgium, Netherlands, Denmark, France, Italy, United Kingdom, Austria, Germany
Clinical Trials on Mesh augmentation
-
Basma AlsheikhCompletedAlveolar Bone AtrophyEgypt
-
GBR AcademyCompletedSoft Tissue Infections | Surgical Procedure, Unspecified | Bone Density | Surgical Wound Dehiscence | Bone Loss in JawItaly
-
University Hospital, GhentJohnson & JohnsonCompleted
-
Hams Hamed AbdelrahmanCompletedAlveolar Bone LossEgypt
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
Blokhin's Russian Cancer Research CenterRecruitingRectal Cancer | Surgery | Neoplasms Malignant | Hernia IncisionalRussian Federation
-
Regionshospital NordjyllandRecruitingAbdominal Wall Hernia | Epigastric Hernia Repair | Umbilical Hernia RepairDenmark
-
Al-Azhar UniversityCompleted
-
Helsinki University Central HospitalCompletedInguinal Hernia | SurgeryFinland